ARCHIVES

Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996

Nurses’ Work Environment Needs Change To Protect Patients From Errors, IOM Says

November 28, 2003

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

Meta-Analysis Finds ESA Use In Oncology Associated With Increases In VTE, Mortality.

February 29, 2008

NCAB Orders 23 Unfunded Organ Site Grants Paid, Sends Contradictory Messages On Program Revisions

December 3, 1982

Shubik Group Finishes Criteria, Presents Final Draft To Rauscher

July 2, 1976